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Introduction
Healthcare costs and the disease burden of chronic 
illness are rising, along with a growing ageing popula-
tion [1–6]. This underlines an increasing need for 
accurate tools for monitoring the epidemiology of 
chronic conditions, including incidence, prevalence 
and health-related quality of life (HRQoL) for use in 
healthcare planning, decision making, forecasting 
and research.
Existing studies measure population prevalence 
estimates of chronic conditions very differently, 
varying from community-based health surveys and 
screening examinations to register-based studies. 
The choice of definitions, methods and source of 
data may affect the findings substantially. Among 
the obvious strengths of using registers is the fact 
that the diagnoses are reported by clinicians; and 
thus are preferred by other studies as the registers 
are free of unwanted self-reported bias [7]. Also, 
the completeness of data is mostly high. In addi-
tion, register data is often available up-to-date and 
cost-effectiveness is high, since the data has already 
been collected [8].
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Introduction: The aim of the current study was to present and discuss a broad range of register-based definitions of chronic 
conditions for use in register research, as well as the challenges and pitfalls when defining chronic conditions by the use 
of registers. Materials and methods: The definitions were defined based on information from nationwide Danish public 
healthcare registers. Medical and epidemiological specialists identified and grouped relevant diagnosis codes that covered 
chronic conditions, using the International classification System version 10 (IcD-10). Where relevant, prescription and 
other healthcare data were also used to define the chronic conditions. Results: We identified 199 chronic conditions and 
subgroups, which were divided into four groups according to a medical judgment of the expected duration of the conditions, 
as follows. category I: Stationary to progressive conditions (maximum register inclusion time of diagnosis since the start 
of the register in 1994). category II: Stationary to diminishing conditions (10 years of register inclusion after time of 
diagnosis). category III: Diminishing conditions (5 years of register inclusion after time of diagnosis). category Iv: borderline 
conditions (2 years of register inclusion time following diagnosis). The conditions were primarily defined using hospital 
discharge diagnoses; however, for 35 conditions, including common conditions such as diabetes, chronic obstructive lung 
disease and allergy, more complex definitions were proposed based on record linkage between multiple registers, including 
registers of prescribed drugs and use of general practitioners’ services. Conclusions: This study provided a catalog of 
register-based definitions for chronic conditions for use in healthcare planning and research, which is, to the 
authors’ knowledge, the largest currently compiled in a single study. 
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The Scandinavian countries have a long tradition 
of keeping high-quality registers on all key aspects 
of the life of its citizens, including healthcare, and 
these registers are essential for healthcare planning 
and epidemiological research. Several studies have 
used registers to estimate the burden of chronic dis-
ease [2,4,9–14]; however, these studies usually only 
covered a few selected chronic conditions. To the 
authors’ knowledge, there are so far no existing 
register-based studies that have aimed to present a 
catalogue of register-based definitions on a broad 
range of chronic conditions.
The aim of this study was to present a compre-
hensive catalogue of register-based definitions of 
chronic conditions, and to discuss the challenges 
and pitfalls when doing so. Also, an important aim 
was to ensure the usefulness of the definitions in 
both the register and the linked survey studies. This 
study is the first in a series that estimate both 
nationwide population prevalence and HRQoL, 
based on surveys of the 199 chronic conditions in 
Denmark [15].
Materials and methods
The definitions within current study were defined 
based on information from nationwide Danish 
public registers.
The Danish National Patient Register (NPR). The 
NPR was established in 1977 and holds data on 
diagnosis, treatments, patient type, dates and more 
from all nationwide hospital treatments for every 
patient contact, at the individual level [16,17]. The 
NPR was originally established for administrative 
use, but has over the years increasingly been used for 
research, due to the richness and quality of the data. 
From 1995, the register included both somatic and 
psychiatric patients, as well as emergency patients; 
and with the coming of private healthcare in the 
2000s, private hospital and clinic patients were 
included in the NPR from 2003. The use of the 
International classification System’s IcD-10 codes 
was implemented in 1994 [16].
The NPR is based on the attending physician’s 
reports of patient diagnosis and treatments, which 
are collected in data servers at the hospitals on a 
daily basis and later sent to NPR. The diagnoses are 
reported at hospital discharge and after every out-
patient contact or treatment, for each patient. 
Reporting to the NPR is mandatory, according to 
Danish law. The patient diagnoses are reported as 
being:
1. Primary (A), i.e. an ‘action’ diagnosis or the first-
treated and main illness of interest;
2. Secondary diagnosis (b), i.e. secondary diagnosis 
of relevance for treatment; or
3. Additional diagnosis (+), identified for up to 
19 diagnoses, but these were not necessarily 
treated or of relevance for the specific hospital 
contact.
The NPR includes data on both inpatients and 
outpatients, and emergency patients [16]; however, 
the emergency patients were excluded from the 
present study at all times, as the validity of an emer-
gency diagnosis has not been adequately shown 
[18,19].
The Danish National Psychiatry Central Research 
Register (PCRR). To increase the accuracy and pre-
cision of psychiatric diagnoses, the PcRR [20] was 
also employed in this study. The PcRR was first 
started in 1938, but was made national in 1969; 
and it includes information on all psychiatry admis-
sions at Danish psychiatric hospitals. The register 
also comprised nationwide inpatients and outpa-
tients, as well as emergency visits and IcD-10 diag-
noses from 1995 (when the register also became 
an integrated part of the NPR) on [20]. besides 
the diagnosis, the PcRR also contains informa-
tion including date, patient discharge information, 
type of referral and place of treatment. The PcRR 
data is collected and reported by the attending 
physicians.
National Health Service Register (NHSR). The 
NHSR [21,22] comprises information from services 
and activities of primary care health professionals 
who were contracted to the Danish nationwide, 
public, tax-funded healthcare system. This includes 
information from all general practitioners (gPs), 
practicing medical specialists, dentists, physiothera-
pists, psychologists, chiropodists and chiropractors. 
The NHSR contains information used for economic 
settlement of services with the government, and also 
from 1990 for research purposes; thus, the NHSR 
was included in the current study to link the ser-
vices (e.g. patient blood samples, diabetes tests, 
lung tests, different laboratory tests, the types of 
consultation and referrals to specialists) to specific 
diagnoses, where possible. The data is reported 
electronically every week through the gP invoices 
to the Regional Health Administration, which is 
afterwards passed on to the Danish National board 
of Health [21].
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The Danish National Prescription Register (DNPR).  
The DNPR [23,24] was established in 1994 and 
it contains information on all prescribed medicine 
at an individual level, redeemed outside hospitals 
(pharmacies), for all Danish individuals. All medi-
cine is reported using the Anatomical Therapeutic 
chemical classification (ATc) code, the date and 
personal identification number for linkage to other 
registers; however, the DNPR does not provide infor-
mation on over-the-counter (OTc) drugs, nor drugs 
dispensed at hospitals.
All Danish pharmacies are obligated to report 
any dispensed prescriptions electronically to the 
Danish Medicines Agency, enhancing the validity of 
the register. In practice, all drug packages are 
labeled with a barcode matching the drug’s article 
number. Thus, information bias, and inter- and 
intra-observer bias, are unlikely to occur in the 
DNPR, ensuring high-quality data; however, natu-
rally the DNPR does not document ingestion of the 
drugs (primary non-compliance); therefore, the 
register is a surrogate measure for the patient’s real 
ingestion of the drug [23]. The DNPR is included in 
the present study to increase the accuracy of several 
definitions, by linking specific drugs to specific con-
ditions where possible (i.e. like NHSR, we used the 
DNPR to identify patients whom were exclusively 
diagnosed and treated for their chronic condition in 
the primary care sector).
The Danish Civil Registration System (DCRS) and 
linkage to healthcare registers. In Denmark, all per-
sons alive and living are registered in the DcRS; 
which includes the patient name, gender, birthdate 
or age, place of residence, whether they are alive or 
their death, and more [25,26]. The DcRS identi-
fies inhabitants by a unique 10-digit personal iden-
tification number (their ‘cPR’ number). This 
allows record linkage across time on an individual 
level, for data from complete national registers 
including the DcRS and different healthcare regis-
ters of a current study. The full Danish population 
aged ⩾ 16 years consisted of 4,555,439 citizens on 
1 January 2013.
Identifying and classifying chronic conditions
A medical review of the definitions was done in 
cooperation with experienced physicians, including 
specialists in public health diseases, diseases of 
the circulatory system, psychiatric conditions, mus-
culoskeletal diseases, specialists in general medi-
cine and clinical epidemiologists, as well as other 
experienced experts in the field (working with 
research, data management and disease estima-
tion). The medical review and ratification included 
identifying the IcD-10 codes of chronic conditions 
and assessing the average duration of the identi-
fied conditions. Finally, physicians and epidemiol-
ogists identified conditions that required more 
complex register-based definitions, including use of 
prescription and health services data, and reviewed 
and ratified the complex register definitions. The 
medical review, involved physicians, and a descrip-
tion of the process and considerations of the work 
are presented in more details in the online supple-
mentary material.
chronic conditions were defined in accordance 
with other international studies [27–30]: “We 
defined a person as having a chronic condition if that 
person’s condition had lasted or was expected to 
last 12 or more months and resulted in functional 
limitations and/or the need for ongoing medical 
care.” [28].
The definition was used to identify the condi-
tions with an expected duration of at least 12 
months and their corresponding IcD-10 codes. In 
the case of disagreements or doubt of chronicity, the 
definitions of the conditions were compared to pre-
vious work where possible, to make a decision 
[27,29,30]. Finally, the chosen and chronic IcD-10 
codes were grouped into 199 clinically meaningful 
groups, using the standard IcD-10 groupings and 
subgroupings.
because no absolute ‘cutpoints’ or gold stand-
ards existed regarding the size of the grouped condi-
tions, two criteria were used (besides ensuring 
clinically meaningful groups of conditions based on 
the IcD-10 groupings). First, the conditions were 
grouped based on the existing two- or three-level 
IcD-10 codes (e.g. c56 or M797) where clinically 
advised. Secondly, as the catalogue was also 
intended to be used in linkage with larger surveys, a 
test sample of 56,988 respondents [31,32] was 
applied, along with a minimum requirement of 50 
persons within every condition, for proper statistical 
analysis. If the statistical requirement could not be 
reached, the condition was grouped into the previ-
ous, nearest and broader IcD-10 level if possible; or 
kept at the two or three IcD-10 levels based on a 
clinical assessment (see the online supplementary 
material).
Starting with approximately 22,000 IcD-10 codes 
and conditions, we ended up with 199 conditions 
and groups of conditions comprising, to the authors’ 
knowledge, most chronic conditions, by using the 
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above criteria and definition. A few conditions could 
not meet the 50-person requirement and could not 
be collapsed in a clinically meaningful way into other 
conditions. besides the 199 conditions, five groups of 
medications for common conditions were also 
defined: Depression, antipsychotic, anxiety, heart 
failure and ischemic heart medication.
Duration of conditions: Chronicity
While the above definition of ‘chronic’ solely outlines 
a condition as chronic when it has existed for a mini-
mum of 12 months, it does not take into account that 
not all chronic conditions will have a lifelong pres-
ence. Since the expected duration in fact varies 
across different chronic conditions, the conditions 
were grouped into one of four categories, according 
to their expected duration:
1. category I: Stationary to progressive chronic 
conditions (no time limit equals inclusion time 
going back from the time of interest, for as long as 
valid data were available. In the current study, 
this starting point was defined by the introduc-
tion of the IcD-10 diagnosis coding in Denmark, 
in 1994);
2. category II: Stationary to diminishing chronic 
conditions (10 years of register inclusion time, 
to the time of interest);
3. category III: Diminishing chronic conditions 
(5 years of register inclusion time, to the time of 
interest); and
4. category Iv: borderline chronic conditions 
(2 years of register inclusion time, to the time of 
interest).
The grouping of the conditions into one of the four 
categories was based on a medical assessment of the 
average duration of the individual conditions from 
first identification and diagnosis in the registers.
This was done to ensure with best clinical cer-
tainty that the condition was present when looking 
back in registers from the time of interest. For 
instance, the categorization of inclusion times defined 
whether a person reported with depression once in 
2008 or later is to be considered to have a chronic 
condition at the time of interest (on for example, 1 
January 2013). In consequence, if a diagnosis was 
identified in the NPR once or more in the specified 
inclusion time period, it was considered as chronic, 
according to our criteria. For the category III dimin-
ishing chronic conditions (e.g. depression), a condi-
tion was included as chronic if it was found at least 
once in the register within the 5 years leading to 1 
January 2013 (Figure 1).
The complex definitions for selected conditions 
and medicine
For 35 conditions, more complex definitions were 
created using medication records, gP services and 
hospital treatments where possible, besides the 
diagnosis codes; but also solely by diagnosis codes 
in clinically reviewed combinations, for some condi-
tions (Table I). For example, the conditions were 
chosen if they were primarily treated in primary 
care and thus not reported by diagnosis from hospi-
tals, making several registers necessary to capture 
the condition; or if the clinical experience and lit-
erature suggested complex combinations of diagno-
sis codes for better precision of a specific condition. 
Finally, five different medications comprising differ-
ent, non-IcD-10 specific chronic conditions were 
also added besides the 199 conditions, as they were 
of general interest.
Where possible, the complex definitions were 
inspired by existing research, including those in ‘The 
Danish clinical Registries’ (TDcR), a collection of 
disease-specific clinical databases [33,34] with clini-
cally validated and tested definitions, the Research 
centre for Prevention and Health [10,35,36], the 
Statens Serum Institute (SSI) register of eight 
selected chronic conditions [37,38], and different 
studies referenced in Table I.
Figure 1. Example of the four categories of chronicity and the inclusion time periods, based on a “time of interest” set to 1 January 2013.
 at Aalborg University Library on June 21, 2016sjp.sagepub.comDownloaded from 
466  M. F. Hvidberg et al.
because the existing literature often had a differ-
ent purpose than that of the current study, or fewer 
registers to include, it is important to underline 
that the majority of the definitions in the present 
study are not identical to those used in existing lit-
erature, but are inspired by them. For example, we 
have added medicine to the existing TDcR defini-
tions where clinically relevant to best capture the 
disease population, or we have divided conditions 
into more subgroups than the existing literature, in 
order to get more detailed conditions (e.g. diabetes, 
chronic lower respiratory disease and heart condi-
tions). The definitions in this catalogue have been 
adjusted to suit the purpose of best capturing the 
condition at a specific time, while several existing 
databases estimate yearly incidence or specific hos-
pital procedures, making the adjustments necessary 
here.
results
The definitions and the four categories of 
chronicity
The 199 conditions, their definitions and their allo-
cation to one of the four categories of chronicity, 
are shown in Table I and Table II. Table I shows the 
more complex definitions. All 199 conditions reflect 
both primary (A), secondary (b) and additional (+) 
diagnoses; and they include data on both inpatients 
and outpatients, unless otherwise specified.
Examples:
1. category I: Stationary to progressive chronic condi-
tions are sclerosis, Parkinson’s disease, schizo-
phrenia, Type 1 diabetes and chronic obstructive 
pulmonary disease (cOPD). These conditions 
are not expected to improve, but may remain sta-
ble or progress.
2. category II: Stationary to diminishing chronic 
conditions are cancers and strokes. common to 
these are that they are either stationary or they 
may have a possibility of recovering for the 
better.
3. category III: Diminishing chronic conditions are 
depression, sleep disorders and varices. Here, we 
do not expect any of the conditions to be station-
ary chronic (although this may occur in a minor-
ity of the patients), and we cannot be certain that 
the condition will still be present 5 years after the 
first identified diagnosis.
4. category Iv: Borderline chronic conditions are her-
nias and ulcers, as mentioned, but also varices 
and eye conditions such as cataracts. They were 
included since they may exist for a longer time 
than 12 months; however, they are often treated 
with success and cured. borderline chronic con-
ditions such as stomach ulcers or hernias were 
discussed, but considered chronic in coherence 
with other research [30].
The complex definitions and medicine
The TDcR definitions define groups of IcD-codes 
in combination with different age groups, for some 
conditions (e.g. cOPD, osteoporosis and diabetes). 
The existing TDcR definitions mostly use a 1-year 
inclusion period, but we expanded into the above 
inclusion time periods. contrary to the TDcR 
definitions, diabetes was subdivided into three 
groups (Type I, II and others), also using medicine 
and age criteria, and partly inspired by Thomsen 
et al. [39]. besides the TDcR-inspired conditions, 
other complex definitions using several registers 
were also constructed as the diagnoses alone by 
experts and clinicians were not considered sufficient 
to include the condition. For example, respiratory 
allergy, rheumatoid arthritis, osteoporosis, diabetes 
Type I and Type II, and cOPD all had different 
medications included, besides the IcD-10 diagno-
ses, as shown in Table I.
The choice of complex conditions not sufficiently 
captured using the hospital discharge diagnosis 
alone as they were often treated in primary care, is 
coherent with the existing studies referenced and 
with most major public health conditions, but with a 
few more common conditions (e.g. psoriasis, ulcers, 
hemorrhoids, migraine, epilepsy, thyrotoxicosis and 
glaucoma). Medication indication codes, the labels of 
the prescribed medicines for the condition, were 
used to identify the specific condition, as some drugs 
have several indications (for example epilepsy and 
depression medicine, heart and circulatory medi-
cine). This was done with caution, and mostly in 
combination with already known drugs, as their 
validity is not known and needs to be investigated 
further.
Finally, we added five groups based solely on med-
icine, as broad ‘condition’ categories of general inter-
est (depression, psychosis, anxiety, heart failure and 
ischemic heart disease medicine). This was done to 
ensure the inclusion of patients from primary care 
who were not expected to be captured elsewhere 
using diagnosis codes, and where it had not been 
possible to use medicine to identify a specific condi-
tion, because the medicines are used for a variety of 
conditions.
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Table I. The 35 (33+2) complex definitions and five medicine definitions.
No. condition IcD-10 category Definitions
1 brain cancer 
[40,41]
c71, c75.1–75.3, 
D33.0–33.2, 
D35.2–35.4, 
D43.0–43.2, 
D44.3–44.5 (brain). 
c70, D32, D42 
(brain membrane). 
c72, D33.3–33.9, 
D43.3–43.9 (cranial 
nerve, spinal cord)
cat. II (DIAg)b
2 Diseases of the 
thyroid
E00–04, E06, E07 cat. III (DIAg)b and/or (MEDIcINE10)c including all prescriptions with 
ATc: H03.
EXcLUDED: If defined with thyrotoxicosis.
3 Thyrotoxicosis E05 cat. III (DIAg)b and/or (MEDIcINE)c including all prescriptions with 
ATc: H03b and H03c.
4 Diabetes Type 1 
[13,37,38,42]
E10 cat. I (DIAg)b and (MEDIcINE)c. Patients that have had a minimum 
of two medicine prescriptions, any time since 1995, with ATc: 
A10A (insulin prescription); and/or: all patients who have gotten at 
least one IcD-10 E10 or IcD-8 249 diagnosis code since 1987, or 
IcD-8 code 250 from 1977 to 1986, before age 30 at the time of 
contact and at a minimum one ATc: A10A prescription anytime. 
EXcLUDED: All diagnoses and medicine contacts for 1 year after 
first diagnosed with IcD-10: O24.4 / IcD-8 63474 (pregnancy 
diabetes), and/or all, if defined with diabetes Type 2 below.
5 Diabetes Type 2 
[13,37–39,42,43]
E11 cat. II (DIAg)b with minimum 2 diagnoses/contacts. And/or:
(MEDIcINE10)c ATc: A10A and if age 40+ at time of 
prescription. And/or ATc: A10b at age 30+ at time of prescription. 
And all needs a minimum of two prescriptions. And/or:
(SERvIcE10)d: ‘Foot therapy for diabetes patients’ (specialty 54) 
once within the last 10 years, or ‘bloodsucherer meassurements’ 
(service numbers XX7136 and XX7159, except specialties 44, 45, 
46 in places of the two X’s) twice each year, during a period of a 
minimum of 5 years (blood2in5) or
5 times within 1 year, once within the last 10 years (blood5in1).
EXcLUDED: (MEDIcINE10)c A10A medicine inclusion 
criterion is  excluded if a patient is diagnosed with diabetes Type 1 
as defined above. (MEDIcINE10)c A10b and DIAgb criteria are 
excluded if a patient is diagnosed the first time with Type 1 before 
age 30 at the time of contact, and prescribed ATc: A10A anytime 
as described in the above definition of type I. Service inclusion 
criteria are excluded if a patient is defined with diabetes Type 1 as 
defined above. All diagnosis and medicine contacts are excluded 
from and 1 year after first diagnosed with O24.4 (pregnancy 
diabetes). And/or if women are diagnosed with E282 (PcOS) 
or have been treated with PcOS medicine ATc: A10bA02 in 
combination with either ATc: g03gb02 or g03Hb.
6 Diabetes others 
[42]
E12–14 cat. III (DIAg)b.
EXcLUDED: If diabetes Types I and II already defined.
7 Disorders of 
lipoprotein 
metabolism/ other 
lipidemias
E78 cat. III (DIAg)b and/or (MEDIcINE5)c, including all prescriptions with 
ATc: c10.
8 cystic fibrosis 
[38,37]
E84 cat. I (DIAg)b and/or (MEDIcINE)c including all prescriptions 
with indication codes 369 (cystic fibrosis) or 433 (against lung 
infection in cystic fibrosis) and/or ATc: R05cb13 (cystic fibrosis-
specific medicine).
9 Dementia [35] F00, g30, F01, 
F02.0, F03.9, 
g31.8b, g31.8E, 
g31.9, g31.0b
cat. I (DIAg)b all patients of age 60+ at contact, who have had a 
minimum of one contact with one of the IcD-10 codes on the 
left since 1994. And/or: (MEDIcINE)c patients who have had 
a minimum of one medicine prescription with either indication 
codes 329 (dementia), 330 (Alzheimer’s dementia) or 331 
(Alzheimer’s disease) and/or ATc: N06D.
10
 
Schizophrenia 
[34,37,38]
F20 cat. I (DIAg)b and
EXcLUDED: If complete remission (IcD-10: F20.05, F20.15, 
F20.25, F20.35, F20.45, F20.55, F20.65, F20.85, F20.95).
 (continued)
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No. condition IcD-10 category Definitions
11 bipolar affective 
disorder
F30–F31 cat. I (DIAg)b and/or (MEDIcINE)c ATc: N05A or N06A with indication 
codes 491 (of mania) or 631 (treatment of bipolar disorder).
12 Depression 
[34,44]
F32, F33, F34.1, 
F06.32
cat. III (DIAg)b and/or (MEDIcINE5)c ATc: N06A with indication 
code 168 (against depression).
13 OcD F42 cat. II (DIAg)b and/or (MEDIcINE10)c ATc: N06A with indication 
codes 472 (from OcD) or 596 (the treatment of OcD).
14 Hyperkinetic 
disorders 
(ADHD)
F90 cat. I (DIAg)b and/or (MEDIcINE)c including all prescriptions with 
indication code 376 (against hyperactivity) or 391 (for treatment 
of ADHD). And/or: ATc: N06bA.
15 Parkinson’s 
disease
g20, g21, g22, 
F02.3
cat. I (DIAg)b and/or (MEDIcINE)c, including all prescriptions with 
ATc: N04.
16 Epilepsy [45,46] g40–g41 cat. III (DIAg)b and minimum of two NPR contacts with a minimum of 
one of the diagnosis codes on the left, within the last 5 years. And/
or: (MEDIcINE5)c ATc: N03, N05bA, N05cD with indication 
codes 155 (epilepsy) or 753 (prolonged epileptic seizures).
17 Migraine g43 cat. II (DIAg)b and/or (MEDIcINE10)c, including all prescriptions 
with: ATc: N02c. And/or: either indication codes 56 (for 
the prevention of migraine), 153 (migraine) or 594 (migraine 
prophylaxis).
18 glaucoma [47] H40–H42 cat. III (DIAg)b and/or (MEDIcINE5)c, including all prescriptions with 
ATc: S01E.
19 Ménière’s disease H810 cat. I (DIAg)b and/or (MEDIcINE)c, including all prescriptions with 
indication code 194 (against Ménière’s disease).
20 Aortic and mitral 
valve disease [48]
I05, I06, I34, I35 cat. III (DIAg)b
21 Hypertensive 
diseases [49,50]
I10–I15 cat. III (DIAg)b and/or (MEDIcINE5)c, including all prescriptions with 
a combination treatment with at least two of the following classes 
of antihypertensive drugs with ATc: codes:
• α Adrenergic blockers (c02A, c02b, c02c);
•  Non-loop diuretics (c02DA, c02L, c03A, c03b, c03D, 
c03E, c03X, c07c, c07D, c08g, c09bA, c09DA, 
c09XA52);
• vasodilators (c02Db, c02DD, c02Dg, c04, c05);
• β blockers (c07);
• calcium channel blockers (c07F, c08, c09bb, c09Db);
• Renin-angiotensin system inhibitors (c09).
22 Heart failure 
[34,51]
I11.0, I13.0, I13.2, 
I42.0, I42.6, I42.7, 
I42.9, I50.0, I50.1, 
I50.9
cat. II (DIAg)b and only A-diagnosis.
23 Stroke [34,52] I60, I61,I63–I64,
Z501 (rehabilitation)
cat. II (DIAg)b I60, I61, I63, I64 with A-diagnosis only. And/or DZ501 as 
A-diagnosis in combination with I61, I63–I64 as A- or b-diagnosis. 
24 Hemorrhoids I84 cat. Iv (DIAg)b and/or (MEDIcINE2)c, including all prescriptions with 
ATc: c05A and indication code 63 (for hemorrhoids).
25 Respiratory 
allergy [35]
J30, except J30.0 cat. I (DIAg)b and/or (MEDIcINE)c ATc: v01AA02, v01AA03, 
v01AA05, v01AA11; R01Ac, R01AD, R06A, S01g, R01bA52.
120Aa chronic lower 
respiratory 
diseases [35]
J40–J43, J47 cat. I (DIAg)b and/or (MEDIcINE)c including all prescriptions with 
indication codes 127, 396 or 740 (bronchitis). And/or ATc: R03Ac, 
R03AK, R03bA, R03bb, R03cc, R03DA, R03Dc, v03AN01.
EXcLUDED if they have cystic fibrosis as defined; and/or if 
medicine comprises cOPD and asthma-specific medicine, as 
defined below.
26 cOPD [35,53,54] J44, J96, J13–J18 cat. I (DIAg)b All patients of minimum 30 years of age at contact who 
have had a minimum of one contact with J44 with an A-diagnosis. 
And/or J96 with A-diagnosis in combination with J44 with 
b-diagnosis. And/or J44 or J96 with b-diagnosis in combination 
with J13–18 with A-diagnosis. And/or: (MEDIcINE)c including 
all prescriptions with indication codes 379 or 464. And/or 
ATc: R03Ac18, R03Ac19, R03AL02, R03AL03, R03AL04, 
R03bb04, R03bb05, R03bb06, R03DX07 (cOPD-specific 
medicine). And/or:
(SERvIcE10)d if patients have had a minimum of two lab 
services within the last 12 months. Lab services: (80)7113 (lung 
spirometer test), (80)7121 (lung function test).
EXcLUDED if has cystic fibrosis as defined.
Table I. (continued)
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No. condition IcD-10 category Definitions
27 Asthma, status 
asthmaticus [35]
J45–J46 cat. I (DIAg)b and/or (MEDIcINE)c, including all prescriptions with 
indication codes 202 (for asthma) or 203 (for the prevention 
of asthma) and/or all prescriptions with ATc: R03Dc03. 
EXcLUDED if has cystic fibrosis as defined.
28 Ulcers K25–K27 cat. Iv (DIAg)b and/or (MEDIcINE2)c including all prescriptions with 
indication codes 003 (for ulcer) or 465 (against ulcer (Helicobacter 
pylori eradication)). And/or ATc: A02bD. Only one prescription 
needed.
29 Psoriasis L40 cat. I (DIAg)b and/or (MEDIcINE)c, including all prescriptions ATc: 
D05 unless D05bb. And/or ATc: D05bb with either indication 
codes 221 (psoriasis), 231 (psoriasis with infection), 243 (against 
scalp psoriasis), 246 (against infected psoriasis) or 344 (for 
psoriasis of the scalp).
30Aa Inflammatory 
polyarthropathies 
and ankylosing 
spondylitis [35,36]
M05–M14, M45 cat. I (DIAg)b and/or (MEDIcINE)c, including all prescriptions 
with indication codes 147 (RA), 402 (RA), 641 (for RA), 406 
(ankylosing spondylitis) or 407 (bechterew’s disease). And/
or ATc: M01c, LO4AA13, A07Ec01, P01bA01, P01bA02, 
M04AA01, M04AA03, M04Ab01.
30 RA [35,36] M05, M06, M07.1, 
M07.2, M07.3, 
M08, M09
cat. I (DIAg)b and/or (MEDIcINE)c including all prescriptions with 
indication codes 147 (RA), 402 (RA) or 641 (for RA) and/or 
ATc: M01c, LO4AA13, A07Ec01, P01bA01, P01bA02.
31
 
Inflammatory 
polyarthropathies, 
except RA 
[35,36]
M074–M079, 
M10–M14, M45
cat. I (DIAg)b and/or (MEDIcINE10)c including all prescriptions with 
indication code 406 (ankylosing spondylitis) or 407 (bechterew’s 
disease). And/or ATc: M01c, LO4AA13, A07Ec01, P01bA01, 
P01bA02, M04AA01, M04AA03, M04Ab01.
EXcLUDED if indication codes equal 147, 402 or 641 of RA at 
any time.
32
 
Osteoporosis 
[35,37,38]
M80–M81 cat. I (DIAg)b All patients of age 50+ at contact that have had 
minimum one contact with one of the IcD-10 codes on the left 
since 1994. And/or:
(MEDIcINE)c all medicine prescriptions with either ATc: 
M05bA01, M05bA04, M05bA06, M05bA07, M05bb01, 
M05bb03, g03Xc01, H05AA02, H05AA03.
33
 
 
 
cRF [14] N18 cat. I (DIAg)b and/or:
(c1) included the procedure codes concerning kidney transplant 
(KKAS10 or KKAS20) just once since 2000. And/or:
(c2) condition 1: The patient has been in dialysis (SKS code 
bJFD) at least 12 times (for at least one period) of 90–97 days 
after 1 January 2000, in which either the distance between the first 
and last dialysis is 90–97 days, or:
(c3) condition 2: at least one dialysis was reported as chronic 
peritoneal dialysis (SKS codes: bJFD21, bJFD22, bJFD23, 
bJFD24, bJFD25 or bJFD27).
1M Depression 
medicine
None (MEDIcINE2)c ATc: N06A.
2M Antipsychotic 
medicine
None (MEDIcINE2)c ATc: N05A.
3M Indication 
prescribed anxiety 
medicine
None (MEDIcINE2)c all prescriptions with either indication codes 163 
(for anxiety) or 371 (for anxiety, addictive).
4M Heart failure 
medication [37,38]
None (MEDIcINE2)c including all prescriptions of ATc: c01AA05, 
c03, c07 or c09A with indication code 430 (for heart failure).
5M Ischemic heart 
medication [35]
None (MEDIcINE2)c including all prescriptions of ATc: c01A, 
c01b, c01D, c01E.
aconditions numbered with “A” are overlapping with other conditions and thus, not counted twice. Use the different definitions according to specific needs.
b DIAg: All patients, any age unless specified otherwise, that have had a minimum of one hospital or outpatient contact, with one of the IcD-10 diagnosis codes 
of the condition within the defined inclusion time described by categories I–Iv. both ‘open’ (ongoing treatment) and ‘closed’ (finalized treatment) contacts, 
as well as primary (A), secondary (b) and additional (+) diagnosis are included.
c MEDIcINE: All patients that have had a minimum of two medicine prescriptions as defined by the ATc codes and/or indication codes within a period of 12 
months, at last one time during the specified period from the time of interest. MEDIcINE10 indicates that medication criteria have been included for 10 years 
from the time of interest, MEDIcINE5 for 5 years, and MEDIcINE2 for 2 years. If no number is specified after a medicine, the inclusion time is the same as 
that in the diagnosis category. For medicine using indication codes, medicine can only be included at the earliest from 2004, which is when indication codes 
were first reported. Records of ATc medicine prescriptions exist from 1995.
d SERvIcE10: Patients that have had a minimum of one healthcare SERvIcE during the last 10 years.
ADHD: attention-deficit hyperactivity disorder; ATc: Anatomic Therapeutic chemical classification; cat: category; cOPD: chronic obstructive pulmonary 
disease; cRF: chronic renal failure; IcD: International classification of Disease; OcD: obsessive-compulsive disorder; RA: rheumatoid arthritis; SERvIcE10: 
Patients with a minimum of one healthcare SERvIcE during the last 10 years.
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Table II. The 166 diagnosis-based definitions of somatic and mental chronic conditions and their categories, sorted by IcD-10 diagnosis.
No. Somatic conditions IcD-10 category Definitions
34 chronic viral hepatitis b18 cat. Iv (DIAg)a
35 HIv b20–b24 cat. I (DIAg)a
36 Malignant neoplasms of other and unspecified 
localizations
c00–c14; c30–c33; 
c37–c42; c45–c49; c69; 
c73–74; c754–c759
cat. II (DIAg)a
37 Malignant neoplasms of digestive organs c15–c17; c22–c26 cat. II (DIAg)a
38 Malignant neoplasm of the colon c18 cat. II (DIAg)a
39 Malignant neoplasms of the rectosigmoid junction, 
rectum, anus and anal canal
c19–c21 cat. II (DIAg)a
40 Malignant neoplasm of bronchus and lung c34 cat. II (DIAg)a
41 Malignant melanoma of skin c43 cat. II (DIAg)a
42 Other malignant neoplasms of skin c44 cat. Iv (DIAg)a
43 Malignant neoplasm of the breast c50 cat. II (DIAg)a
44 Malignant neoplasms of female genital organs c51–c52; c56–c58 cat. II (DIAg)a
45 Malignant neoplasm of the cervix uteri, corpus uteri and 
part unspecified
c53–c55 cat. II (DIAg)a
46 Malignant tumor of the male genitalia c60, c62–c63 cat. II (DIAg)a
47 Malignant neoplasm of prostate c61 cat. II (DIAg)a
48 Malignant neoplasms of urinary tract c64–c68 cat. II (DIAg)a
49 Malignant neoplasms of ill-defined, secondary and 
unspecified sites, and of independent (primary) multiple 
sites
c76–c80, c97 cat. II (DIAg)a
50 Malignant neoplasms, stated or presumed to be primary, 
of lymphoid, haematopoietic and related tissue
c81–c96 cat. II (DIAg)a
51 In situ neoplasms D00–D09 cat. II (DIAg)a
52 Hemolytic anemias D55–D59 cat. II (DIAg)a
53 Aplastic and other anaemias D60–D63 cat. II (DIAg)a
54 Other anemias D64 cat. II (DIAg)a
55 coagulation defects, purpura and other hemorrhagic 
conditions
D65–D69 cat. II (DIAg)a
56 Other diseases of blood and blood-forming organs D70–D77 cat. II (DIAg)a
57 certain disorders involving the immune mechanism D80–D89 cat. III (DIAg)a
58 Disorders of other endocrine glands E20–E35, except E30 cat. III (DIAg)a
59 Metabolic disorders E70–E77; E79–E83; E85; 
E88–E89
cat. II (DIAg)a
60 Inflammatory diseases of the central nervous system g00–g09 cat. I (DIAg)a
61 Systemic atrophies primarily affecting the central 
nervous system and other degenerative diseases
g10–g14, g30–g32 cat. I (DIAg)a
62 Extrapyramidal and movement disorders g23–g26 cat. I (DIAg)a
63 Sclerosis g35 cat. I (DIAg)a
64 Demyelinating diseases of the central nervous system g36–g37 cat. I (DIAg)a
65 Other headache syndromes g44 cat. III (DIAg)a
66 Transient cerebral ischemic attacks and related 
syndromes and vascular syndromes of the brain in 
cerebrovascular diseases
g45–g46 cat. II (DIAg)a
67 Sleep disorders g47 cat. III (DIAg)a
68 Disorders of the trigeminal nerve and facial nerve 
disorders
g50–g51 cat. I (DIAg)a
69 Disorders of other cranial nerves, cranial nerve disorders 
in diseases classified elsewhere, nerve root and plexus 
disorders, and nerve root and plexus compressions in 
diseases classified elsewhere
g52–g55 cat. I (DIAg)a
70 Mononeuropathies of the upper limb g56 cat. I (DIAg)a
71 Mononeuropathies of the lower limb, other 
mononeuropathies and mononeuropathy in diseases 
classified elsewhere
g57–g59 cat. I (DIAg)a
72 Polyneuropathies and other disorders of the peripheral 
nervous system
g60–g64 cat. I (DIAg)a
73 Diseases of myoneural junction and muscle g70–g73 cat. I (DIAg)a
74 cerebral palsy and other paralytic syndromes g80–g83 cat. I (DIAg)a
75 Other disorders of the nervous system g90–g99 cat. I (DIAg)a
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76 Disorders of eyelid, lacrimal system and orbit H02– H06 cat. Iv (DIAg)a
77 corneal scars and opacities H17 cat. II (DIAg)a
78 Other disorders of the cornea H18 cat. II (DIAg)a
79 Diseases of the eye lens (cataracts) H25–H28 cat. Iv (DIAg)a
80 Disorders of the choroid and retina H31–H32 cat. I (DIAg)a
81 Retinal vascular occlusions H34 cat. I (DIAg)a
82 Other retinal disorders H35 cat. I (DIAg)a
83 Retinal disorders in diseases classified elsewhere H36 cat. III (DIAg)a
84 Disorders of the vitreous body and globe H43–H45 cat. Iv (DIAg)a
85 Disorders of optic nerve and visual pathways A: H46, H48 and b: H47 A: cat. I (DIAg)a
 b: cat. III  
86
 
 
Disorders of ocular muscles, binocular movement, 
accommodation and refraction
A: H49 and b: H50, H52 
and c: H51
A: cat. III (DIAg)a
b: cat. Iv  
c: cat. I  
87 visual disturbances H53 cat. I (DIAg)a
88 blindness and partial sight H54 cat. I (DIAg)a
89 Nystagmus and other irregular eye movements and 
other disorders of eye and adnexa
H55, H57 cat. I (DIAg)a
90 Otosclerosis H80 cat. II (DIAg)a
91 Other diseases of the inner ear H83 cat. II (DIAg)a
92 conductive and sensorineural hearing loss H90 cat. II (DIAg)a
93 Other hearing loss and other disorders of ear, not 
elsewhere classified
H910, H912, H913, 
H918, H930, H932, H933
cat. II (DIAg)a
94 Presbycusis (age-related hearing loss) H911 cat. II (DIAg)a
95 Hearing loss, unspecified H919 cat. II (DIAg)a
96 Tinnitus H931 cat. I (DIAg)a
97 Other specified disorders of the ear H938 cat. II (DIAg)a
98 Angina pectoris I20 cat. III (DIAg)a
99 Acute myocardial infarction and subsequent myocardial 
infarction
I21–I22 cat. III (DIAg)a
100 Acute myocardial infarction complex/other I23–I24 cat. III (DIAg)a
101 chronic ischemic heart disease I25 cat. III (DIAg)a
102 Pulmonary heart disease and diseases of pulmonary 
circulation
I26–I28 cat. III (DIAg)a
103 Acute pericarditis I30 cat. II (DIAg)a
104 Other forms of heart disease I31–I43, except I34–I35 
and I42
cat. II (DIAg)a
105 Atrioventricular and left bundle-branch block I44 cat. II (DIAg)a
106 Other conduction disorders I45–46 cat. II (DIAg)a
107 Paroxysmal tachycardia I47 cat. II (DIAg)a
108 Atrial fibrillation and flutter I48 cat. II (DIAg)a
109 Other cardiac arrhythmias I49 cat. II (DIAg)a
110 complications and ill-defined descriptions of heart 
disease and other heart disorders in diseases classified 
elsewhere
I51–52 cat. II (DIAg)a
111 cerebrovascular diseases I62,I65–I68 cat. II (DIAg)a
112 Sequelae of cerebrovascular disease I69 cat. II (DIAg)a
113 Atherosclerosis I70 cat. II (DIAg)a
114 Aortic aneurysm and aortic dissection I71 cat. III (DIAg)a
115 Diseases of arteries, arterioles and capillaries I72, I74, I77–I79 cat. III (DIAg)a
116 Other peripheral vascular diseases I73 cat. III (DIAg)a
117 Phlebitis, thrombosis of the portal vein and others I80–I82 cat. III (DIAg)a
118 varicose veins of lower extremities I83 cat. Iv (DIAg)a
119 Esophageal varices (chronic), varicose veins of 
other sites, other disorders of veins, nonspecific 
lymphadenitis, other noninfective disorders of lymphatic 
vessels and lymph nodes, other and unspecified 
disorders of the circulatory system
I85–I99 , except I89 and 
I95
cat. III (DIAg)a
120 bronchitis, not specified as acute or chronic, simple 
and mucopurulent chronic bronchitis, and unspecified 
chronic bronchitis
J40–J42 cat. II (DIAg)a
Table II. (continued)
 (continued)
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121 Emphysema J43 cat. II (DIAg)a
122 bronchiectasis J47 cat. II (DIAg)a
123 Other diseases of the respiratory system J60–J84; J95, J97–J99 cat. II (DIAg)a
124 Inguinal hernia K40 cat. Iv (DIAg)a
125 ventral hernia K43 cat. Iv (DIAg)a
126 crohn’s disease K50 cat. I (DIAg)a
127 Ulcerative colitis K51 cat. II (DIAg)a
128 Other noninfective gastroenteritis and colitis K52 cat. III (DIAg)a
129 IbS K58 cat. II (DIAg)a
130 Other functional intestinal disorders K59 cat. III (DIAg)a
131 Diseases of liver, biliary tract and pancreas K71–K77; K86–K87 cat. II (DIAg)a
132 Infectious arthropathies M01–M03 cat. II (DIAg)a
133 Polyarthrosis (arthrosis) M15 cat. I (DIAg)a
134 coxarthrosis (arthrosis of hip) M16 cat. I (DIAg)a
135 gonarthrosis (arthrosis of knee) M17 cat. I (DIAg)a
136 Arthrosis of first carpometacarpal joint and other 
arthrosis
M18–M19 cat. I (DIAg)a
137 Acquired deformities of fingers and toes M20 cat. II (DIAg)a
138 Other acquired deformities of limbs M21 cat. II (DIAg)a
139 Disorders of patella (knee cap) M22 cat. II (DIAg)a
140 Internal derangement of knee M230, M231, M233, 
M235, M236, M238
cat. Iv (DIAg)a
141 Derangement of meniscus due to old tear or injury M232 cat. Iv (DIAg)a
142 Internal derangement of knee, unspecified M239 cat. Iv (DIAg)a
143 Other specific joint derangements M24, except M240–M241 cat. Iv (DIAg)a
144 Other joint disorders, not elsewhere classified M25 cat. Iv (DIAg)a
145 Systemic connective tissue disorders M30–M31,M35-M36 cat. I (DIAg)a
146 Systemic lupus erythematosus M32 cat. I (DIAg)a
147 Dermatopolymyositis M33 cat. I (DIAg)a
148 Systemic sclerosis M34 cat. I (DIAg)a
149 Kyphosis, lordosis M40 cat. I (DIAg)a
150 Scoliosis M41 cat. I (DIAg)a
151 Spinal osteochondrosis M42 cat. I (DIAg)a
152 Other deforming dorsopathies M43 cat. I (DIAg)a
153 Other inflammatory spondylopathies M46 cat. I (DIAg)a
154 Spondylosis M47 cat. I (DIAg)a
155 Other spondylopathies and spondylopathies in diseases 
classified elsewhere
M48, M49 cat. II (DIAg)a
156 cervical disc disorders M50 cat. Iv (DIAg)a
157 Other intervertebral disc disorders M51 cat. Iv (DIAg)a
158 Other dorsopathies, not elsewhere classified M53 cat. Iv (DIAg)a
159 Dorsalgia M54 cat. Iv (DIAg)a
160 Disorders of muscles M60–M63, except M600 cat. Iv (DIAg)a
161 Synovitis and tenosynovitis M65 cat. Iv (DIAg)a
162 Disorders of the synovium and tendon M66–68 cat. Iv (DIAg)a
163 Soft tissue disorders related to use, overuse and pressure M70 cat. Iv (DIAg)a
164 Fibroblastic disorders M72 cat. I (DIAg)a
165 Shoulder lesions M75 cat. Iv (DIAg)a
166 Enthesopathies of the lower limb, excluding the foot M76 cat. Iv (DIAg)a
167 Other enthesopathies M77 cat. Iv (DIAg)a
168 Rheumatism, unspecified M790 cat. II (DIAg)a
169 Myalgia M791 cat. II (DIAg)a
170 Other soft tissue disorders not elsewhere classified M792– M794; M798–
M799
cat. II (DIAg)a
171 Other soft tissue disorders not elsewhere classified: pain 
in limb
M796 cat. Iv (DIAg)a
172 Fibromyalgia M797 cat. I (DIAg)a
173 Osteoporosis in diseases classified elsewhere M82 cat. I (DIAg)a
174 Adult osteomalacia and other disorders of bone density 
and structure
M83, M85, except M833 cat. I (DIAg)a
Table II. (continued)
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175 Disorders of continuity of bone M84 cat. Iv (DIAg)a
176 Other osteopathies M86–M90 cat. I (DIAg)a
177 Other disorders of the musculoskeletal system and 
connective tissue
M95–M99 cat. I (DIAg)a
178 congenital malformations of the nervous, circulatory, 
respiratory system; cleft palate and cleft lip; urinary 
tract; bones and muscles; other and chromosomal 
abnormalities not elsewhere classified
Q00–Q07; Q20–Q37; 
Q60–Q99
cat. I (DIAg)a
179 congenital malformations of eye, ear, face and neck Q10–Q18 cat. I (DIAg)a
180 Other congenital malformations of the digestive system Q38–Q45 cat. I (DIAg)a
181 congenital malformations of the sexual organs Q50–Q56 cat. I (DIAg)a
No. Mental conditions IcD-10 category Definitions
182 Organic, including symptomatic, mental disorders F04–F09 cat. I (DIAg)a
183 Mental and behavioral disorders due to use of alcohol F10 cat. III (DIAg)a
184 Mental and behavioral disorders due to psychoactive 
substance use
F11–F19 cat. III (DIAg)a
185 Schizotypal and delusional disorders F21-F29 cat. I (DIAg)a
186 Mood (affective) disorders F340, F348-F349, 
F38-F39
cat. I (DIAg)a
187 Phobic anxiety disorders F40 cat. II (DIAg)a
188 Other anxiety disorders F41 cat. II (DIAg)a
189 Post-traumatic stress disorder F431 cat. I (DIAg)a
190 Reactions to severe stress and adjustment disorders F432–F439 cat. III (DIAg)a
191 Dissociative (conversion) disorders, somatoform 
disorders and other neurotic disorders
F44, F45, F48 cat. I (DIAg)a
192 Eating disorders F50 cat. III (DIAg)a
193 behavioral syndromes associated with physiological 
disturbances and physical factors
F51-F59 cat. III (DIAg)a
194 Emotionally unstable personality disorder F603 cat. I (DIAg)a
195 Specific personality disorders F602, F604–F609 cat. I (DIAg)a
196 Disorders of adult personality and behavior F61–F69 cat. I (DIAg)a
197 Mental retardation F70–F79 cat. I (DIAg)a
198 Disorders of psychological development F80–F89 cat. I (DIAg)a
199 behavioral and emotional disorders with onset usually 
occurring in childhood and adolescence
F91–F99 cat. I (DIAg)a
a DIAg: All patients, any age unless specified otherwise, that have had a minimum of one hospital or outpatient contact with one of the IcD-10 diagnosis codes 
of the condition within the defined inclusion time described by categories I–Iv. both ‘open’ (ongoing treatment) and ‘closed’ (finalized treatment) contacts 
as well as primary (A), secondary (b) and additional (+) diagnosis are included.
HIv: Human immunodeficiency virus; IcD-10: International classification System version 10; IbS: irritable bowel syndrome.
Table II. (continued)
discussion
To the authors’ knowledge, this study provides the 
first complete catalogue of definitions of chronic 
conditions that is based on data from population-
based healthcare registers. The definitions have been 
reviewed and ratified by physicians and epidemiolo-
gists to ensure their clinical coherence, significance, 
and hence, applicability for use in future studies. 
Further detailed descriptions of the process and 
medical considerations are found on the online sup-
plementary material, including examples of the prev-
alence within some complex definitions, compared to 
non-complex definitions of the same conditions.
For this discussion, we used a suggested frame-
work of three of seven factors of importance when 
assessing the value of secondary data [8]:
1. completeness of registration of individuals;
2. Accuracy and degree of completeness of the reg-
istered data;
3. Size of the data source;
4. Registration period;
5. Data accessibility, availability and cost;
6. Data format; and
7. Possibilities of linkage with other data sources 
(record linkage).
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In the following, we discuss the strengths and 
weaknesses of numbers 1, 2 and 4 regarding the 
issues of quality and validity relevant for this study. 
Finally, we discuss the current study in comparison 
with other studies and future studies.
Completeness of registration of individuals
While population-based registers by definition hold 
the complete data of a population, they are often 
only complete within specific healthcare sectors. For 
example, a weakness of traditional studies using hos-
pital discharge registers is their inability to identify 
patients with chronic conditions who have been 
treated exclusively by gPs. The lack of diagnosis 
data from primary care may reduce the inclusion of 
less severe conditions that are normally not referred 
for hospital treatment (e.g. less severe levels of oste-
oporosis, cOPD, Type 2 diabetes, allergies and 
asthma), which may only have been diagnosed and 
treated in primary care. In the present study, we 
aimed to overcome this limitation by also including 
prescription data when defining some of the condi-
tions; however, some less severe conditions may still 
be under-reported using the definitions of the pre-
sent study, amongst other reasons due to the fact 
that a few of the included conditions are often 
treated by private specialists and are not included 
sufficiently in the registers employed, or not diag-
nosed at all. The extent of under-reporting, validity 
and under-diagnosing is examined in other studies, 
with varying results of specific conditions and meth-
ods [7,55–59]. besides the conditions mentioned 
above, this may include less severe conditions such 
as cataracts, age-related hearing loss, and less severe 
mental conditions like some types of anxiety or 
depression. This issue may lead to an underestima-
tion of their true prevalence or other biased esti-
mates depending on the outcomes used [60].
A disadvantage of community-based survey stud-
ies compared to register-based studies is the prob-
lem with non-responders due to people being in 
prison, homeless people, people living in institu-
tions, those currently in inpatient treatment and sur-
vey non-responders in general [60]; which might 
lead to underestimation of more severe conditions. 
Thus, the strength of the definitions of the current 
study is an expected more complete identification of 
patients with chronic conditions, in particular 
patients with more severe conditions. Previous stud-
ies also show varying or poor overlap between regis-
ter-based and self-reported data, for a number of 
conditions [36,61,62]. consequently, register-based 
studies contrast with and complement community-
based survey studies.
The accuracy and degree of completeness of the 
registered data
Although misclassification and non-registration of 
a diagnosis are well-known issues in community-
based surveys, due to incorrect self-reported condi-
tions, forgotten reports of past disorders, etc. [60]; 
similar limitations may also exist in register-based 
studies, regarding the accuracy of the diagnosis. 
One reason is the different coding practices for 
diagnoses, as well as incomplete coding practices 
between or even within hospitals [8,12]. In addi-
tion, non-reports of conditions, clinical disagree-
ments and different interpretation of the IcD-10 
diagnostic inclusion criteria may affect registration 
[8,12]. Hence, the risks of misclassification are 
known for some complex, multifaceted conditions 
[63,64], but it is also the case that some common 
and well-defined conditions are not always suffi-
ciently reported in the NPR, according to an older 
study [65].
Furthermore, since the NPR is also used for mon-
itoring the productivity of the individual hospital 
departments, economic incentives might bias the 
coding practice towards more costly diagnoses and 
treatments [16]. Yet nothing suggests a systemic bias 
in misclassification for all conditions, and the validity 
of several diagnoses that have previously been exam-
ined using medical records as a gold standard were 
reported to be high [19,60,66–70]; however, the 
validity of the diagnoses appear to vary across condi-
tions [59], although we have sought to incorporate 
experience from existing validated conditions into 
the definitions. caution is therefore advised using the 
definitions, and further validation and ongoing 
adjustment of the algorithms are warranted, since 
coding practices for diagnoses and the completeness 
of data can change over time.
Another issue in register-based studies is the lack 
of accuracy when using non-diagnosis registers from 
the primary sector. Since medication, services and 
registered treatments are often used for a variety of 
conditions, these cannot always be used alone as 
reliable predictors. Thus, the use of, for example, 
medication to define conditions has only been 
applied for specific cases, and definitions were devel-
oped based on a clinical judgment of coherence 
between the medication and conditions. For instance, 
Type 1 diabetes was defined as having a Type 1 diag-
nosis and insulin use.
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As around a quarter of the medication, on average, 
is missing yearly indication codes, all from before 
2004, and the validity of the existing medication indi-
cation codes may be questionable, these should be 
(and were) used conservatively. Thus, known disease-
specific medication was preferred and included 
without indication codes where possible, such as 
for thyrotoxicosis, diabetes, lipid disturbances, 
Parkinson’s disease, hypertension, respiratory allergy 
and more; however, for several conditions such as 
depression, bipolar affective disorder, obsessive com-
pulsive disorder (OcD), heart failure, epilepsy and 
hemorrhoids, there was a necessity to use indication 
codes to differentiate different conditions from non-
disease medicine. Since the completeness of indica-
tion codes is low, these conditions will properly 
underestimate the true prevalence; however, since 
the alternative was not using the medicine given, this 
still represents an improvement from the alternative 
of using diagnosis alone, if the condition is often 
treated in primary care or by private specialists.
The registration period
The main issue regarding the registration period is 
the potential risk of changes over time in diagnostic 
criteria that may bias the registrations [8,12]. This is 
mainly solved by excluding IcD-8 and solely using 
IcD-10, but there may still be changes within IcD-
10 diagnostic criteria over the period since 1994.
The changing of diagnostic criteria is a particular 
challenge for studies using longer time periods than 
here [8]; which is why we suggest limiting longer 
inclusion times to a minimum, in order to ensure 
accuracy. For example, we reduced the inclusion 
time to 5 years for epilepsy, as well as requiring a 
minimum of two hospital diagnoses, since the risk of 
misclassification (besides high variability in chronic-
ity) was considerable [45,46,71]. The issues are even 
more prevalent for more disputed and complex con-
ditions; for example chronic fatigue syndrome (cFS), 
a severe, long-term chronic and common condition 
affecting 0.2–0.4% of the population, but is only 
reported for 0.014 per cent in the NPR [63]. In the 
case of cFS, cultural interpretation of the 
condition and differences across countries might 
also affect the registrations [63]. In essence, this will 
bias results, but cannot be managed before clinical 
practice is changed.
Comparisons with other studies
The strength of the current study is that the defini-
tions were reviewed and ratified by physicians and 
epidemiologists, and included existing studies and 
medical experts, enhancing their clinical relevance. 
The conditions were assessed individually, and it 
was decided to focus on the conditions needing 
complex definitions and the use of several registers 
to ensure the most accurate representation and 
inclusion. Furthermore, already established regis-
ter-based definitions, created by specialists in their 
field, were used as inspiration, which may increase 
the transferability and comparability of those defini-
tions presented here.
As stated above, there is no uniform government or 
professionally advised definition of ‘chronic condi-
tion’ in use, nor any fully suitable definition for regis-
ter studies, since no existing definitions set the 
maximum time limits of chronicity. Thus, an advan-
tage of this study was the production of the four 
clinically evaluated and differentiated categories of 
chronicity, with different inclusion times. In addition, 
previous Scandinavian register studies had usually 
used a 1–5-year inclusion time, often limited by the 
maximum data length available, with some only 1 
year depending on the purpose and some recom-
mending more; and for a limited and selected variety 
of conditions or more broadly defined disease groups, 
compared to the present study [4,9,10,12,72]. Hence, 
one of the obvious strengths and new innovations of 
the current study compared to other register studies 
were the long register time used, as well as the four 
differentiated time inclusion categories used on all 
conditions [2,4,9–12]. The relatively longer inclusion 
time enhances the possibility of including several con-
ditions, since it was expected that, due to severity, the 
majority of patients with chronic conditions would at 
some time be reported as inpatients or outpatients in 
hospitals, or by medications and services.
Moreover, an obvious benefit compared to the 
previous studies was the large number of conditions 
included in this single study. While previous register 
studies mostly identify up to approximately 15 condi-
tions [2,4,9–13], the purpose of this study was to 
include most possible IcD-10-defined chronic 
conditions into one of these groups of conditions, 
including both somatic and psychiatric conditions.
Summary and future studies
In summary, the definitions were as a minimum 
expected to provide a lower limit of prevalence in 
future studies, especially for some of the less severe 
conditions, because the registers used do not account 
for individuals not seeking treatment. On the con-
trary, more severe conditions that are most often 
treated are expected to have a higher accuracy, 
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compared to other studies and study designs, even 
though there may be inaccuracies and differences in 
the coding of diagnoses in the NPR [16]. In general, 
it was expected that the definitions will produce rea-
sonably representative estimates concerning the 
consequences and epidemiology of the majority of 
chronic conditions, and be free of self-reported bias; 
however, an ongoing revision and thorough clinical 
validation of specific conditions using for example 
clinical records [8] is needed by researchers in their 
field, to ensure improvement in the validity of the 
definitions. We also recommend that future studies 
should explore the extent of possible underestima-
tion or overestimation of the prevalence of less severe 
conditions, using the definitions and differences for 
self-reported conditions. Further studies should also 
explore how possible underestimation can be coun-
teracted by including self-reported community-
based surveys for the less severe conditions, if 
available [10,36], as well as methods for counteract-
ing the lack of IcD-10 diagnosis accuracy when 
using surveys. Additionally, so far the definitions 
cannot be applied for incidence studies using the 
four categorizations; thus, future studies should 
investigate how the definitions are best applied 
within incidence studies. At this time, the authors 
recommend using the defined IcD-10 codes and/or 
medications, in combination with the chosen inci-
dence timeframe wherein only new incidences are 
included. Moreover, future studies should also inves-
tigate how to apply a multimorbidity framework, as 
suggested by other studies [73–75]. Although a sim-
ple approach defining multi-morbidity as having two 
or more conditions could easily be applied, it is rec-
ommended that future studies also identify the pat-
terns or clusters of comorbidities, as these are 
expected to vary in severity and to be of importance 
in unfolding the burden of chronic disease.
This study provides a comprehensive catalogue of 
IcD-10-based definitions. The definitions can be 
used in national monitoring of the prevalence of 
chronic conditions, as well as estimation of the 
HRQoL associated with a condition, for example, 
through the use of the National Health Profiles [31]. 
Although the definitions are created for long term 
data series and registers that are mostly availably in 
Scandinavian countries, the IcD-10 groupings and 
the use of ATc-medicine can still be adopted for use 
in medico-administrative data in other countries 
that are based on both public and private registers, 
while the inclusion times must be adjusted accord-
ing to the specific time series available. In the end, 
these definitions are expected to enable policy mak-
ers to assess the burden of chronic conditions in 
more detail, with accuracy, and for more conditions 
than other studies for comparison; and without the 
burden of using several and often non-comparable, 
different studies and estimates.
Conclusions
This study provides the results and the methodology 
behind the creation of a compilation of definitions 
for a variety of IcD-10 register-based groups of 
chronic conditions, which is, to the authors’ knowl-
edge, the largest currently compiled.
The prevalence rates and HRQoL estimates based 
on the definitions presented here will be investigated 
in planned future studies; and will thus provide 
important information on the burden of illness for 
use in etiologic studies, health economics and other 
research areas, as well as in healthcare planning.
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